Prostatic biology, histologic patterns and clinical consequences of transitional cell carcinoma

Current Opinion in Urology

Volumn 18, Issue 5, 2008, Pages 508-512

  Lerner, Seth P ^a,b   Colen, John ^a   Shen, Steven ^a  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Bladder cancer; Prostate; Transitional cell carcinoma; Urothelial cancer

Indexed keywords

ADJUVANT CHEMOTHERAPY; BLADDER TUMOR; CANCER DIAGNOSIS; CANCER RISK; CYSTECTOMY; DECISION MAKING; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; HISTOPATHOLOGY; HUMAN; KNOWLEDGE; LYMPHADENECTOMY; PELVIS; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CARCINOMA; REVIEW; RISK ASSESSMENT; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION; URETHRA; URETHRA SURGERY; BLADDER; MALE; METASTASIS; PATHOLOGY; PROSTATE; PROSTATE TUMOR; URETHRA TUMOR;

CARCINOMA, TRANSITIONAL CELL; CYSTECTOMY; HUMANS; MALE; PROSTATE; PROSTATIC NEOPLASMS; URETHRA; URETHRAL NEOPLASMS; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 54549116866     PISSN: 09630643     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOU.0b013e32830b86f9     Document Type: Review

References (33)

1. Wood DP Jr, Montie JE, Pontes JE, et al. Transitional cell carcinoma of the prostate in cystoprostatectomy specimens removed for bladder cancer. J Urol 1989; 141:346-349.
2. Rubenstein AB, Rubnitz ME. Transitional cell carcinoma of the prostate. Cancer 1969; 24:543-546.
3. Shen SS, Lerner SP. Prostatic transitional cell carcinoma: pathologic features and clinical management. Expert Rev Anticancer Ther 2007; 7:1155-1162.
4. Donat SM, Genega EM, Herr HW, et al. Mechanisms of prostatic stromal invasion in patients with bladder cancer: clinical significance. J Urol 2001; 165:1117-1120.
5. Shen SS, Lerner SP, Muezzinoglu B, et al. Prostatic involvement by transitional cell carcinoma in patients with bladder cancer and its prognostic significance. Hum Pathol 2006; 37:726-734.
6. Njinou Ngninkeu B, Lorge F, Moulin P, et al. Transitional cell carcinoma involving the prostate: a clinicopathological retrospective study of 76 cases. J Urol 2003; 169:149-152.
7. Pagano F, Bassi P, Ferrante GL, et al. Is stage pT4a (D1) reliable in assessing transitional cell carcinoma involvement of the prostate in patients with a concurrent bladder cancer? A necessary distinction for contiguous or noncontiguous involvement. J Urol 1996; 155:244-247.
8. Esrig D, Freeman JA, Elmajian DA, et al. Transitional cell carcinoma involving the prostate with a proposed staging classification for stromal invasion. J Urol 1996; 156:1071-1076.
9. Vazina A, Dugi D, Shariat SF, et al. Stage specific lymph node metastasis mapping in radical cystectomy specimens. J Urol 2004; 171:1830-1834.
10. Liedberg F, Anderson H, Blackberg M, et al. Prospective study of transitional cell carcinoma in the prostatic urethra and prostate in the cystoprostatectomy specimen. Incidence, characteristics and preoperative detection. Scand J Urol Nephrol 2007; 41:290-296.
11. KeferJC,VoelzkeBB, FlaniganRC, et al. Risk assessmentfor occult malignancy in the prostate before radical cystectomy. Urology 2005; 66:1251-1255.
12. Huguet J, Crego M, Sabate S, et al. Cystectomy in patients with high risk superficial bladder tumors who fail intravesical BCG therapy: precystectomy prostate involvement as a prognostic factor. Eur Urol 2005; 48:53-59; discussion 59.
13. Schellhammer PF, Bean MA, Whitmore WF Jr. Prostatic involvement by transitional cell carcinoma: pathogenesis, patterns and prognosis. J Urol 1977; 118:399-403.
14. Hardeman SW, Soloway MS. Urethral recurrence following radical cystectomy. J Urol 1990; 144:666-669.
15. Nixon RG, Chang SS, LafleurBJ, et al. Carcinoma in situ and tumor multifocality predict the risk of prostatic urethral involvement at radical cystectomy in men with transitional cell carcinoma of the bladder. J Urol 2002; 167 (2 Pt 1):502-505.
16. Wood DP Jr, Montie JE, Pontes JE, et al. Identification of transitional cell carcinoma of the prostate in bladder cancer patients: a prospective study. J Urol 1989; 142:83-85.
17. Reese JH, FreihaFS, Gelb AB, et al. Transitional cell carcinoma of the prostate in patients undergoing radical cystoprostatectomy. J Urol 1992; 147:92-95.
18. Revelo MP, Cookson MS, Chang SS, et al. Incidence and location of prostate and urothelial carcinoma in prostates from cystoprostatectomies: implications for possible apical sparing surgery. J Urol 2004; 171 (2 Pt 1):646-651.
19. Pettus JA, Al-Ahmadie H, Barocas DA, et al. Risk assessment of prostatic pathology in patients undergoing radical cystoprostatectomy. Eur Urol 2008; 53:370-375. his is a new series reported from Memorial Sloan-Kettering Cancer Center
20. Iselin CE, Robertson CN, Webster GD, et al. Does prostate transitional cell carcinoma preclude orthotopic bladder reconstruction after radical cystoprostatectomy for bladder cancer? J Urol 1997; 58:2123-2126.
21. von Rundstedt FC, Shen SS, Lerner SP. Transurethral resection biopsy of the prostatic and apical margin status at radical cystoprostatectomy. J Urol 2007; 177:549.
22. Lockhart JL, Chaikin L, Bondhus MJ, et al. Prostatic recurrences in the management of superficial bladder tumors. J Urol 1983; 130:256-257.
23. Rikken CH, van Helsdingen PJ, Kazzaz BA. Are biopsies from the prostatic urethra useful in patients with superficial bladder carcinoma? Br J Urol 1987; 59:145-147.
24. Hardeman SW, Perry A, Soloway MS. Transitional cell carcinoma of the prostate following intravesical therapy for transitional cell carcinoma of the bladder. J Urol 1988; 140:289-292.
25. Matzkin H, Soloway MS, Hardeman S. Transitional cell carcinoma of the prostate. J Urol 1991; 146:1207-1212.
26. Vallancien G, Abou El Fettouh H, Cathelineau X, et al. Cystectomy with prostate sparing for bladder cancer in 100 patients: 10-year experience. J Urol 2002; 168:2413-2417.
27. Revelo MP, Cookson MS, Chang SS, et al. Incidence and location of prostate and urothelial carcinoma in prostates from cystoprostatectomies: implications for possible apical sparing surgery. J Urol 2008; 179 (5 Suppl):S27-S32.
28. Lerner SP, Shen SS. Pathologic assessment and clinical significance of prostatic involvement by transitional cell carcinoma and prostate cancer. Urol Oncol 2008 [Epub ahead of print].
29. Blick C, Jones A, Fawcett DP. Clinically significant prostate cancer found incidentally in radical prostatectomy specimens. BJU Int 2007; 99:1170.
30. Abdelhady M, Abusamra A, Pautler SE, et al. Clinically significant prostate cancer found incidentally in radical cystoprostatectomy specimens. BJU Int 2007; 99:326-329.
31. Colombo R, Bertini R, Salonia A, et al. Nerve and seminal sparing radical cystectomy with orthotopic urinary diversion for select patients with superficial bladder cancer: an innovative surgical approach. J Urol 2001; 165:51-55; discussion 55.
32. Spitz A, Stein JP, Lieskovsky G, et al. Orthotopic urinary diversion with preservation of erectile and ejaculatory function in men requiring radical cystectomy for nonurothelial malignancy: a new technique. J Urol 1999; 161:1761-1764.
33. Salem HK. Radical cystectomy with preservation of sexual function and fertility in patients with transitional cell carcinoma of the bladder: new technique. Int J Urol 2007; 14:294-298; discussion 299.